Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2019

Mar 15, 2019

31996_dirs_2019-03-15_00cce96c-f670-4558-b4fb-a7b3839ce942.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2019-03-14

Reporting Person: ANDREWS DEBORAH J (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-03-14 Common Stock Options $35.98 A 16883 Acquired 2029-03-13 Common Stock (16883) Direct

Footnotes

F1: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.